Patents by Inventor Gary Allred
Gary Allred has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260124122Abstract: Disclosed herein are quaternary ammonium silane aqueous hydrogel formulations, including pharmaceutically acceptable aqueous hydrogel formulations, that provide high aqueous stability to an ammonium silane active moiety, as well as methods of use and manufacture.Type: ApplicationFiled: December 19, 2025Publication date: May 7, 2026Applicant: TOPIKOS SCIENTIFIC, INC.Inventors: Gary Allred, Lany Liebeskind, William R. Cast, Carl Hilliard
-
Publication number: 20260091049Abstract: Provided herein are ammonium silanes, compositions, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals. The ammonium silanes and compositions described herein can also be used as a preservative, disinfectant, or in another anti-microbial use.Type: ApplicationFiled: December 5, 2025Publication date: April 2, 2026Applicant: TOPIKOS SCIENTIFIC, INC.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Patent number: 12564572Abstract: An aqueous clear topical ocular solution of levcromakalim, or a pharmaceutically acceptable salt thereof, is provided in an effective therapeutic amount to treat the anterior portion of the human eye without the use of a covalent prodrug approach, a polymeric delivery system or a high level of toxic components, and with at least 4 months of shelf life stability, through the use of specifically discovered combinations of excipient components.Type: GrantFiled: October 4, 2024Date of Patent: March 3, 2026Assignees: QLARIS BIO, INC., MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHInventors: Thurein M. Htoo, Michael P. Fautsch, Gary Allred, Ralph Casale, Barbara M. Wirostko
-
Patent number: 12564573Abstract: An aqueous clear topical ocular solution of levcromakalim, or a pharmaceutically acceptable salt thereof, is provided in an effective therapeutic amount to treat the anterior portion of the human eye without the use of a covalent prodrug approach, a polymeric delivery system or a high level of toxic components, and with at least 4 months of shelf life stability, through the use of specifically discovered combinations of excipient components.Type: GrantFiled: October 4, 2024Date of Patent: March 3, 2026Assignees: QLARIS BIO, INC., MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHInventors: Thurein M. Htoo, Michael P. Fautsch, Gary Allred, Ralph Casale, Barbara M. Wirostko
-
Publication number: 20250387366Abstract: Aqueous ocular topical pharmaceutical formulations are provided that deliver an effective amount of (lev)cromakalim or a pharmaceutically acceptable salt thereof to treat an anterior or a posterior ocular disorder that responds to (lev)cromakalim, including glaucoma.Type: ApplicationFiled: August 28, 2025Publication date: December 25, 2025Applicants: QLARIS BIO, INC., MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHInventors: Thurein M. Htoo, Michael P. Fautsch, Gary Allred, Ralph Casale, Barbara M. Wirostko
-
Publication number: 20250304605Abstract: Organosilicon quaternary ammonium compounds, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals.Type: ApplicationFiled: November 11, 2024Publication date: October 2, 2025Applicant: TOPIKOS SCIENTIFIC, INC.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Publication number: 20250304604Abstract: Organosilicon quaternary ammonium compounds, their formulations, including lyophilized solid formulations, and methods of use to treat infections in humans and animals.Type: ApplicationFiled: November 11, 2024Publication date: October 2, 2025Applicant: TOPIKOS SCIENTIFIC, INC.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Publication number: 20250257164Abstract: A polymer formed from a first monomer of vinylene carbonate and at least one second monomer different form the first monomer that does not contain a glycidyl group, wherein the molar ratio of the first monomer to the second monomer is from 4:1 to 99:1. The polymer, preferably the copolymer, dissolves metal salts and the composition of the copolymer and metal salt may have an ionic conductivity greater than 0.01 mS/cm. The polymer is suitable for use in various components of solid state batteries.Type: ApplicationFiled: April 25, 2025Publication date: August 14, 2025Applicant: Piersica, Inc.Inventors: Claudiu B. Bucur, Gary Allred
-
Patent number: 12338307Abstract: A polymer formed from a first monomer of vinylene carbonate and at least one second monomer different form the first monomer that does not contain a glycidyl group, wherein the molar ratio of the first monomer to the second monomer is from 4:1 to 99:1. The polymer, preferably the copolymer, dissolves metal salts and the composition of the copolymer and metal salt may have an ionic conductivity greater than 0.01 mS/cm. The polymer is suitable for use in various components of solid state batteries.Type: GrantFiled: May 6, 2024Date of Patent: June 24, 2025Assignee: Piersica, Inc.Inventors: Claudiu B. Bucur, Gary Allred
-
Publication number: 20250127802Abstract: Provided herein are ammonium silanes, compositions, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals. The ammonium silanes and compositions described herein can also be used as a preservative, disinfectant, or in another anti-microbial use.Type: ApplicationFiled: November 4, 2024Publication date: April 24, 2025Applicant: TOPIKOS SCIENTIFIC, INC.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Publication number: 20250108002Abstract: Aqueous ocular topical pharmaceutical formulations are provided that deliver an effective amount of (lev)cromakalim or a pharmaceutically acceptable salt thereof to treat an anterior or a posterior ocular disorder that responds to (lev)cromakalim, including glaucoma.Type: ApplicationFiled: October 4, 2024Publication date: April 3, 2025Applicants: QLARIS BIO, INC., MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHInventors: Thurein M. Htoo, Michael P. Fautsch, Gary Allred, Ralph Casale, Barbara M. Wirostko
-
Publication number: 20250108035Abstract: Aqueous ocular topical pharmaceutical formulations are provided that deliver an effective amount of (lev)cromakalim or a pharmaceutically acceptable salt thereof to treat an anterior or a posterior ocular disorder that responds to (lev)cromakalim, including glaucoma.Type: ApplicationFiled: October 4, 2024Publication date: April 3, 2025Applicants: QLARIS BIO, INC., MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHInventors: Thurein M. Htoo, Michael P. Fautsch, Gary Allred, Ralph Casale, Barbara M. Wirostko
-
Patent number: 12264170Abstract: Organosilicon quaternary ammonium compounds, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals.Type: GrantFiled: April 22, 2024Date of Patent: April 1, 2025Assignee: TOPIKOS SCIENTIFIC, INC.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Publication number: 20250034304Abstract: Polymers formed from a first monomer and at least one second monomer different form the first monomer. The polymer is conformationally formed to dissolve metal salts in order to form a solid electrolyte capable of conducting lithium and other metals, which may be formed into a film, layered, or otherwise configured to conduct lithium within cell(s) of a battery. The polymer is suitable for use in various components of solid state batteries in various environmental conditions. Decomposition reactions of the polymers.Type: ApplicationFiled: July 11, 2024Publication date: January 30, 2025Inventors: Claudiu B. Bucur, Gary Allred
-
Patent number: 12180239Abstract: Organosilicon quaternary ammonium compounds, their formulations, including lyophilized solid formulations, and methods of use to treat infections in humans and animals.Type: GrantFiled: April 15, 2021Date of Patent: December 31, 2024Assignee: Topikos Scientific, Inc.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Patent number: 12134628Abstract: Organosilicon quaternary ammonium compounds, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals.Type: GrantFiled: April 18, 2022Date of Patent: November 5, 2024Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Publication number: 20240309026Abstract: Organosilicon quaternary ammonium compounds, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals.Type: ApplicationFiled: April 22, 2024Publication date: September 19, 2024Applicant: TOPIKOS SCIENTIFIC, INC.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Publication number: 20240301109Abstract: A polymer formed from a first monomer of vinylene carbonate and at least one second monomer different form the first monomer that does not contain a glycidyl group, wherein the molar ratio of the first monomer to the second monomer is from 4:1 to 99:1. The polymer, preferably the copolymer, dissolves metal salts and the composition of the copolymer and metal salt may have an ionic conductivity greater than 0.01 mS/cm. The polymer is suitable for use in various components of solid state batteries.Type: ApplicationFiled: May 6, 2024Publication date: September 12, 2024Applicant: Piersica, Inc.Inventors: Claudiu B. Bucur, Gary Allred
-
Patent number: 12024533Abstract: Organosilicon quaternary ammonium compounds, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals.Type: GrantFiled: December 22, 2022Date of Patent: July 2, 2024Assignee: Topikos Scientific, Inc.Inventors: Gary Allred, Lanny Liebeskind, William R. Cast, Carl Hilliard
-
Patent number: 12006387Abstract: A polymer formed from a first monomer of vinylene carbonate and at least one second monomer different form the first monomer that does not contain a glycidyl group, wherein the molar ratio of the first monomer to the second monomer is from 4:1 to 99:1. The polymer, preferably the copolymer, dissolves metal salts and the composition of the copolymer and metal salt may have an ionic conductivity greater than 0.01 mS/cm. The polymer is suitable for use in various components of solid state batteries.Type: GrantFiled: November 13, 2023Date of Patent: June 11, 2024Assignee: PIERSICA, INC.Inventors: Claudiu B. Bucur, Gary Allred
